Keywords: Atherosclerosis, Atherosclerosis
Motivation: The identification and intervention of atherosclerotic plaques is effective to prevent cardiovascular events. However, specific detection methods in vivo are lacking.
Goal(s): The objective of this study was to prepare M2-PNVs@Fe3O4 and to improve the accuracy of contrast agent delivery.
Approach: In vitro, the contrast agent was co-cultured with Raw264.7, HUVEC and collagen, respectively. In vivo, the fluorescence imaging and MRI contrast-enhancing effect was investigated in mice.
Results: The contrast agent has good targeting of vulnerable plaques, and high SNR were obtained on T2WI sequences. In addition, the contrast agent effectively attenuates the levels of inflammatory factors.
Impact: We prepared biomimetic contrast agent to improve the targeting specificity of vulnerable plaques, which is a major innovation in the application of bionic nanotechnology to atherosclerosis. Meanwhile, this study provided ideas for the integration diagnosis and treatment of contrast agents.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords